• Return to Headlines

Shares of CombiMatrix Rank the Highest in terms of Cash Flow in the Life Sciences Tools & Services Industry (CBMX, ACCL, HBIO, CCEL, PRXL)

Written on Fri, 07/30/2010 - 4:08am
By Chip Brian

Below are the top five companies in the Life Sciences Tools & Services industry as measured by the price to cash flow ratio. Often companies with the lowest ratio present the greatest value to investors.
CombiMatrix (NASDAQ:CBMX) has a price to free cash flow ratio of 1.3x based on a current price of $2.72 and a free cash flow per share of $2.16.
Accelrys (NASDAQ:ACCL) has a price to free cash flow ratio of 10.8x based on a current price of $6.95 and a free cash flow per share of $0.64.
Harvard Bioscience (NASDAQ:HBIO) has a price to free cash flow ratio of 36.5x based on a current price of $3.58 and a free cash flow per share of $0.1.
Cryo-Cell International (NASDAQ:CCEL) has a price to free cash flow ratio of 38.6x based on a current price of $1.3 and a free cash flow per share of $0.03.
Parexel International (NASDAQ:PRXL) has a price to free cash flow ratio of 44.5x based on a current price of $20.93 and a free cash flow per share of $0.47.
SmarTrend is bearish on shares of HBIO and our subscribers were alerted to Sell on May 20, 2010 at $3.82. The stock has fallen 6.3% since the alert was issued.

Keywords: keywords: nasdaq:cbmx combimatrix price to free cash

Ticker(s): CBMX ACCL HBIO CCEL PRXL

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.